Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
11,898 total articles
Clear Secure Chief Accounting Officer Dennis W. Liu sold 7,950 Class A shares on March 2, 2026, generating $386,131 at $48.57 per share. The transaction was carried out automatically under a Rule 10b5-1 plan adopted November 26, 2025, and was disclosed in a Form 4 signed March 4, 2026. The company’s shares are trading close to a 52-week high after …
Trinity Capital Inc. (NASDAQ:TRIN) CEO, President and CIO Kyle Steven Brown purchased 3,333 shares at $14.90 per share on March 2, 2026, a transaction valued at $49,661. The shares trade at $15.11, giving Brown an immediate paper gain. The filing also corrects a prior December 17, 2025 Form 4 that misstated certain holdings. Trinity Capital reporte…
Ronald E. Estes, a director at Trinity Capital Inc. (NASDAQ: TRIN), purchased 200 shares on March 3, 2026, at $14.73 per share for a total of $2,946. The stock trades at $15.11 following the purchase. The firm recently reported fourth-quarter 2025 results that beat expectations and committed $50 million in growth capital to Dwelly, a London-based p…
Q2 Holdings, Inc. executive Kirk L. Coleman completed stock sales totaling $1,932,853 to satisfy tax liabilities related to vesting restricted stock units, while also receiving newly vested performance-based shares. The moves come amid a six-month, 37% slide in the company’s share price and follow a quarterly report that beat revenue and adjusted E…
Q2 Holdings, Inc. (NASDAQ: QTWO) Chief People Officer Kimberly Anne Rutledge sold 23,829 shares of common stock on March 3 and 4, 2026, in transactions mandated to satisfy tax withholding obligations. The sales, reported on an SEC Form 4, were executed at weighted average prices between $49.72 and $49.75 per share, totaling approximately $1.18 mill…
Adaptive Biotechnologies Chief Scientific Officer Harlan S. Robins sold a total of 24,233 shares of company stock on March 2 and March 3, 2026, through transactions disclosed on a Form 4 filing. The sales were made under a Rule 10b5-1 trading plan adopted August 11, 2025. The company recently reported Q4 2025 results that beat expectations and saw …
Zevia PBC director Spence Padraic L. sold 40,000 shares of Class A common stock on March 3, 2026, for a weighted average price between $1.43 and $1.45, totaling $57,516. After the sale, Spence holds 1,555,417 shares directly, including 71,827 restricted stock units. The transaction arrives amid mixed fourth-quarter 2025 results: an EPS of -$0.02 th…
AH Realty Trust director Frederick Blair Wimbush purchased 10,000 shares of the company's common stock on March 3, 2026, for $61,900. The REIT's shares trade at $6.36 and yield 8.81% in dividends, a payout maintained for 13 consecutive years. Wimbush's direct and LTIP holdings are detailed in an SEC filing. Separately, Armada Hoffler Properties rep…
Xencor Inc. reported an insider sale by President and CEO Bassil I. Dahiyat, who sold 6,758 shares on March 3, 2026, for $80,387. Filings show Dahiyat also received restricted stock units and a large option grant that vest over multi-year schedules. Separately, Xencor is negotiating a U.S. royalty payment dispute with Alexion while extending a roya…
Xencor Inc. reported an insider sale by its Senior Vice President and Chief Scientific Officer, alongside disclosures of restricted stock units and option awards. The company is managing a U.S. royalty dispute over Ultomiris while extending its U.S. royalty term until December 2028 and plans a busy 2026 clinical agenda for its XmAb pipeline.
Xencor Inc. (NASDAQ:XNCR) reported an insider sale by SVP and General Counsel Celia Eckert on March 3, 2026, and disclosed an associated equity award and prior acquisition. The transactions come as the stock has risen about 49% over six months but remains down roughly 17% year-to-date. Separately, corporate developments around an Ultomiris royalty …
Alnylam Pharmaceuticals Chief Executive Officer Yvonne Greenstreet sold $2.23 million of company stock on March 2, 2026, while simultaneously receiving multiple equity awards and long-dated options. The transactions occur against a backdrop of solid profitability signals, a high price-to-earnings ratio, and recent quarterly results that beat EPS ex…
Allbirds Chief Executive Officer Joseph Vernachio sold 4,413 shares of Class A common stock on March 3, 2026, in transactions executed to cover tax withholding tied to restricted stock units. The sales, disclosed on a Form 4 filing, totaled $11,872 at a weighted average price of $2.69. The move comes as Allbirds contends with a 22% revenue decline …
Allbirds CFO Ann Mitchell sold 2,200 shares of Class A stock on March 3, 2026, to meet tax withholding obligations tied to vested restricted stock units. The disposal occurred while shares trade near a 52-week low and as the company accelerates a strategy to exit most U.S. full-price retail locations in favor of digital, wholesale and international…
Artivion President and CEO James P. Mackin sold 17,887 shares on March 3, 2026, to satisfy tax withholding tied to the vesting of performance stock units. The sale followed a one-third vesting of PSUs on March 2, 2026; Mackin continues to hold a substantial stake in the company. Separately, Artivion reported Q4 2025 earnings that beat EPS and adjus…
Richard T. Thigpen, Senior Vice President for Corporate Citizenship at Public Service Enterprise Group (NYSE: PEG), sold 4,700 shares on March 3, 2026, for proceeds of $390,100. The trade occurred close to the stock's recent trading level and follows quarterly results that met analyst expectations. Market valuation flags and a recent analyst target…
Jorey Chernett, a roughly 10% owner of Airsculpt Technologies, reported purchases of common stock totaling $192,900 in recent Form 4 filings. The acquisitions were executed on March 3 and March 4, 2026, leaving Chernett with 6,352,611 directly owned shares as the stock trades near its 52-week low of $1.51.
Kratos Defense & Security Solutions CFO Deanna H. Lund sold 4,800 shares on March 2, 2026, under a pre-arranged 10b5-1 trading plan for proceeds totaling $456,394. The company simultaneously disclosed business developments including a roughly $7 million Counter-UAS production contract, deployment of its OpenSpace Platform for small-satellite servic…
Artivion Inc. Chief Commercial Officer John E. Davis sold 4,573 shares on March 3, 2026 to satisfy tax withholding tied to vested performance stock units, while receiving 28,845 shares on March 2, 2026 from the same award. The transactions leave Davis with 230,794 shares. The insider activity comes as the stock trades at $38.50, after a year-to-dat…
Artivion executive Lance A. Berry sold 6,316 shares on March 3, 2026, to satisfy tax liabilities arising from the vesting of performance stock units. The sale followed a March 2, 2026 grant of 40,874 shares valued at $0 and leaves Berry with 210,827 directly owned shares. The trades come amid favorable fourth-quarter 2025 results and an analyst pri…
Christopher Mutz, Head of Rare Disease at ANI Pharmaceuticals Inc. (NASDAQ: ANIP), sold 417 shares on March 2, 2026, receiving $74 per share for a total of $30,858. The transaction occurred as ANIP shares traded near $76.53. The company has reported robust fundamentals, including 44% revenue growth and a market capitalization of $1.6 billion, and p…
Paul Eugene Sparks, a director at Baldwin Insurance Group (NASDAQ: BWIN), recorded two purchases of Class A Common Stock on March 2 and March 3, 2026, totaling $1,001,760. The transactions came as the stock rallied roughly 30% in the previous week but is still down 45.5% over the last year. Sparks also gifted 30,100 shares on March 2 and maintains …
Christopher Iain Parkinson, president of Vuzix Enterprise Solutions, sold 11,663 shares of Vuzix Corp (NASDAQ: VUZI) on March 4, 2026, for $2.6895 a share, generating $31,367 and leaving him with 131,130 shares. The sale was executed to cover a tax liability. The stock is trading at $2.67, down about 12% over the past week, and Vuzix has a market c…
Dynatrace Executive Vice President and Chief Customer Officer Stephen A. McMahon acquired 3,000 shares of Dynatrace common stock on March 3, 2026, for $35.75 per share, a transaction valued at $107,250. The filing shows McMahon now directly holds 3,454 shares. The insider buy follows a 25% decline in the stock over the prior six months; shares have…
Hayward Holdings President and CEO Kevin Holleran disposed of 52,389 shares on March 2, 2026, using a weighted average sale price of $15.7289 for proceeds of about $824,021. The Form 4 filing also shows option exercises and share acquisitions, along with share dispositions to satisfy tax obligations. The company recently reported fourth-quarter 202…
